SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a memecoin on the Bitcoin network, is trending as the community rallies around its potential as the first fair-launched meme on Bitcoin L2 with big names and whales watching. Discussions revolve around its strong community, decentralized nature, and the possibility of reaching $1, with some highlighting its role in driving demand for Bitcoin blockspace. The 'DOG Army' is actively promoting the token, emphasizing its unique position within the Bitcoin ecosystem.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation of a potential licensing deal with AstraZeneca and positive sentiment surrounding its cancer drug, ivonescimab. The community is actively discussing the possibility of a significant upfront payment and the potential for the drug to challenge existing treatments. Anticipation is building as investors await further news and data releases, with some highlighting the stock's high short interest as a catalyst for a potential squeeze.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as community members rally around its potential to become the leading memecoin on the Bitcoin network, with some suggesting it could surpass Dogecoin. Key talking points include its fair launch, decentralized nature, and strong community backing. Many believe it's poised for significant growth and exchange listings.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as a potential Real World Asset (RWA) coin, drawing comparisons to $XRP.X and $XLM.X. The community highlights its low market cap and potential for integration with the XRP ledger, viewing it as an early opportunity. Community members are actively discussing where to buy the coin and sharing enthusiasm for its potential gains.

Sapien is an open protocol for sourcing verified human knowledge at scale. Its network of millions of contributors spans more than 100 countries, ranging from doctors and engineers to artists and students. Together they produce high-quality AI training data, validated through Sapien’s onchain Proof of Quality system. This ensures enterprises and AI developers can access trusted, human-in-the-loop data while transforming fragmented online work into a sustainable, reputation-based profession. Incentives across the network are powered by the $SAPIEN token, an ERC-20 asset on Base.

Sapien

Sapien.X is trending as the community discusses its potential for significant gains, with some drawing comparisons to other recently successful tokens. The token's chart setup and appealing levels are generating interest, while others speculate about potential scams. The recent listing and overall market conditions abroad are also being mentioned as potential catalysts.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending as traders discuss its low float and potential for a significant price surge, reminiscent of other recent low float runners. Community members are highlighting the stock's scarce shares and growing watcher count, suggesting a possible squeeze. Some are pointing to a recent land sale that could boost NAV.

Numeraire

Numeraire is trending as traders discuss a recent investment from a major US bank into the AI-based crypto hedge fund, which some believe could lead to significant growth. The community is actively analyzing price charts, identifying potential breakout points, and anticipating further upward momentum. With a relatively low circulating supply, many are speculating on substantial long-term gains.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

BBBY is trending as the ticker reactivates, sparking confusion and discussion among traders about Overstock's acquisition of the Bed Bath & Beyond brand and its implications for previous shareholders. The community is actively debating the company's future, potential partnerships, and the possibility of a short squeeze, drawing comparisons to the $GME saga. Some investors express skepticism, citing past financial difficulties, while others see potential in the company's blockchain initiatives.

Tidal Trust III - Fundstrat Granny Shots US Large Cap ETF

Fundstrat Granny Shots US Large Cap ETF

The Fundstrat Granny Shots US Large Cap ETF ($GRNY) is trending as investors discuss its holdings and recent performance, with many referencing Tom Lee's bullish outlook and stock-picking strategy. Community members are weighing the ETF's expense ratio against its potential for long-term growth and diversification, with some speculating about future inclusion of specific assets. The ETF is gaining traction as a way to invest in multiple key investment themes and is being compared to benchmark indexes.

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Resmed Inc.

ResMed ($RMD) is trending amid speculation about a potential buyout or partnership with Incannex ($IXHL), driven by positive clinical trial data for a sleep apnea pill that could disrupt the CPAP market. The community is closely watching for an announcement, especially given that a ResMed executive is on Incannex's advisory board, with some speculating this is a strategic move before Phase 3 trials.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is the Options Market Predicting a Spike in Nordson Stock?

Investors need to pay close attention to NDSN stock based on the movements in the options market lately.

Nordson Divests Design & Development Units to Quasar Medical

NDSN offloads its design and development units to Quasar Medical, sharpening its focus on core medical components and fluid solutions.

Nordson Rewards Shareholders With a 5% Dividend Increase

NDSN boosts its dividend 5% to 82 cents, marking 62 straight years of increases and showcasing strong cash flow.

Nordson Corporation Board of Directors Increases Dividend 5 Percent, Marking 62 Consecutive Years of Annual Dividend Increases

Nordson Corporation (Nasdaq: NDSN) today announced that its Board of Directors has approved a five percent increase in the Companys quarterly cash dividend to $0.82 per common share from $0.78. The...

Here's Why You Should Consider Investing in RBC Bearings Stock Now

RBC is gaining traction from aerospace and industrial strength, a healthy backlog and accretive acquisitions.

Company News for Aug 22, 2025

Companies in The News Are: MNSO, NMM, COST, NDSN

Nordson's Q3 Earnings & Revenues Surpass Estimates, Increase Y/Y

NDSN posts double-digit profit and revenue growth in Q3, fueled by acquisitions and strong demand in Asia-Pacific.

LXFR or NDSN: Which Is the Better Value Stock Right Now?

LXFR vs. NDSN: Which Stock Is the Better Value Option?

Nordson stock (NDSN) rose 5.5% in premarket trading on Thursday after the company’s third-quarter earnings topped Wall Street’s estimates.The company reported adjusted earnings of $2.73 per share for the quarter ended July 31, while analysts expected it to post $2.64 per share, according to Fiscal.ai data. The adhesive dispenser maker’s quarterly revenue of $741.5 million also topped estimates of $723.6 million.The Westlake, Ohio-based company reported earnings of $126 million, or $2.22 per share, compared with $117 million, or $2.04 per share, a year earlier.The medical and fluid solutions segment sales jumped 32% to $219 million compared to the same period last year. Last year, the company completed the $815 million acquisition of Atrion Corporation, a medical technology company specializing in infusion and cardiovascular solutions.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/NDSN">Nordson</a> was in the ‘extremely bullish’ territory, while the retail chatter was ‘high.’Advanced technology solutions sales of $171 million increased 17%, driven by a rise in organic sales.However, industrial precision solutions sales of $351 million increased a more modest 1% as a three percentage point favorable currency impact helped mitigate a 2% drop in organic sales.The organic sales decrease was driven by weaker systems demand in polymer processing, offsetting growth in most other product lines.“Fiscal full-year sales are now tracking slightly below the mid-point, and full-year adjusted earnings per share are now tracking slightly above the mid-point of our original guidance,” the company said. Nordson also noted that backlog fell 5% sequentially.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/eurozone-s-factory-activity-surges-to-over-3-year-high-despite-trump-tariffs/chsSA0oRdLU">Eurozone’s Factory Activity Surges To Over 3-Year High Despite Trump Tariffs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Nordson Corporation logo appears on a smartphone screen in this illustration photo in Reno, United States, on December 30, 2024. (Photo by Jaque Silva/NurPhoto via Getty Images)

Why Is Nordson Stock Rising In Premarket Trading? 

The company reported adjusted earnings of $2.73 per share for the quarter ended July 31, while analysts expected it to post $2.64 per share, according to Fiscal.ai data.

Equity

Compared to Estimates, Nordson (NDSN) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Nordson (NDSN) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Nordson Corp. engages in the engineering, manufacture and market of products and systems used for adhesives, coatings, sealants, biomaterials and other materials. It operates through the following segments: Industrial Precision Solutions, Medical and Fluid Solutions and Advanced Technology Solution. The Industrial Precision Solutions segment enhances the technology synergies between adhesive dispensing systems and industrial coating systems to deliver proprietary dispensing and processing technology to diverse end markets. The Medical and Fluid Solutions segment includes components and device solutions for medical, life science, high-tech industrial and other diverse end markets. The Advanced Technology Solution segment integrates proprietary product technologies found in progressive stages of a customer's production processes, such as surface treatment, precisely controlled dispensing of material and post-dispense test and inspection to ensure quality. The company was founded by Eric T. Nord, Evan W. Nord and Walter G. Nord in 1954 and is headquartered in Westlake, OH.

NDSN
Nordson Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NDSN News

NDSN Nordson Corp.